AAAAAA

   
Results: 1-17 |
Results: 17
Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases
Authors: Coghlan, ME Sommadossi, JP Jhala, NC Many, WJ Saag, MS Johnson, VA
Citation: Me. Coghlan et al., Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases, CLIN INF D, 33(11), 2001, pp. 1914-1921
Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection
Authors: Call, SA Saag, MS Westfall, AO Raper, JL Pham, SV Tolson, JM Hellmann, NS Cloud, GA Johnson, VA
Citation: Sa. Call et al., Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection, J INFEC DIS, 183(3), 2001, pp. 401-408
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant
Authors: Johnson, VA Petropoulos, CJ Woods, CR Hazelwood, JD Parkin, NT Hamilton, CD Fiscus, SA
Citation: Va. Johnson et al., Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant, J INFEC DIS, 183(11), 2001, pp. 1688-1693
Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens
Authors: Gilbert, PB Hanna, GJ De Gruttola, V Martinez-Picado, J Kuritzkes, DR Johnson, VA Richman, DD D'Aquila, RT
Citation: Pb. Gilbert et al., Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens, AIDS RES H, 16(14), 2000, pp. 1325-1336
Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels
Authors: Sha, BE Johnson, VA Kendall, MA Haubrich, R Nokta, M Lamb, K Zackin, RA Nail, CD Currier, JS
Citation: Be. Sha et al., Absence of virological changes after acute febrile illnesses in two patients with undetectable pre-illness plasma HIV-1-RNA levels, AIDS, 14(6), 2000, pp. 746-748
Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370
Authors: Kuritzkes, DR Bassett, RL Johnson, VA Marschner, IC Eron, JJ Sommadossi, JP Acosta, EP Murphy, RL Fife, K Wood, K Bell, D Martinez, A Pettinelli, CB
Citation: Dr. Kuritzkes et al., Continued lamivudine versus delavirdine in combination with indinavir and zidovudine or stavudine in lamivudine-experienced patients: results of Adult AIDS Clinical Trials Group protocol 370, AIDS, 14(11), 2000, pp. 1553-1561
Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy
Authors: Precious, HM Gunthard, HF Wong, JK D'Aquila, RT Johnson, VA Kuritzkes, DR Richman, DD Brown, AJL
Citation: Hm. Precious et al., Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy, AIDS, 14(1), 2000, pp. 31-36
Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel
Authors: Hirsch, MS Brun-Vezinet, F D'Aquila, RT Hammer, SM Johnson, VA Kuritzkes, DR Loveday, C Mellors, JW Clotet, B Conway, B Demeter, LM Vella, S Jacobsen, DM Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426
Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase
Authors: Hanna, GJ Johnson, VA Kuritzkes, DR Richman, DD Martinez-Picado, J Sutton, L Hazelwood, JD D'Aquila, RT
Citation: Gj. Hanna et al., Comparison of sequencing by hybridization and cycle sequencing for genotyping of human immunodeficiency virus type 1 reverse transcriptase, J CLIN MICR, 38(7), 2000, pp. 2715-2721
Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine
Authors: Hanna, GJ Johnson, VA Kuritzkes, DR Richman, DD Brown, AJL Savara, AV Hazelwood, JD D'Aquila, RT
Citation: Gj. Hanna et al., Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine, J INFEC DIS, 181(3), 2000, pp. 904-911
HIV-1 entry inhibitors and virus emergence
Authors: D'Aquila, RT Hughes, M Johnson, VA
Citation: Rt. D'Aquila et al., HIV-1 entry inhibitors and virus emergence, NAT MED, 5(10), 1999, pp. 1091-1091
Lamivudine in combination with zidovudine stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial
Authors: Kuritzkes, DR Marschner, I Johnson, VA Bassett, R Eron, JJ Fischl, MA Murphy, RL Fife, K Maenza, J Rosandich, ME Bell, D Wood, K Sommadossi, JP Pettinelli, C
Citation: Dr. Kuritzkes et al., Lamivudine in combination with zidovudine stavudine, or didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial, AIDS, 13(6), 1999, pp. 685-694
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients
Authors: Zhou, XJ Sheiner, LB D'Aquila, RT Hughes, MD Hirsch, MS Fischl, MA Johnson, VA Myers, M Sommadossi, JP
Citation: Xj. Zhou et al., Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients, ANTIM AG CH, 43(1), 1999, pp. 121-128
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol (vol 259, pg 154, 1999)
Authors: Gunthard, HF Leigh-Brown, AJ D'Aquila, RT Johnson, VA Kurizkes, DR Richman, DD Wong, JK
Citation: Hf. Gunthard et al., Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol (vol 259, pg 154, 1999), VIROLOGY, 261(2), 1999, pp. 367-367
Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol
Authors: Gunthard, HF Leigh-Brown, AJ D'Aquila, RT Johnson, VA Kuritzkes, DR Richman, DD Wong, JK
Citation: Hf. Gunthard et al., Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol, VIROLOGY, 259(1), 1999, pp. 154-165
Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy
Authors: Brown, AJL Gunthard, HF Wong, JK D'Aquila, RT Johnson, VA Kuritzkes, DR Richman, DD
Citation: Ajl. Brown et al., Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy, J INFEC DIS, 180(4), 1999, pp. 1043-1049
Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina
Authors: Fiscus, SA Adimora, AA Schoenbach, VJ McKinney, R Lim, W Rupar, D Kenny, J Woods, C Wilfert, C Johnson, VA
Citation: Sa. Fiscus et al., Trends in human immunodeficiency virus (HIV) counseling, testing, and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina, J INFEC DIS, 180(1), 1999, pp. 99-105
Risultati: 1-17 |